Brokerages Set Teleflex Incorporated (NYSE:TFX) Target Price at $152.90

Teleflex Incorporated (NYSE:TFX – Get Free Report) has been assigned a consensus rating of “Hold” from the twelve brokerages that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $152.90.

TFX has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Wednesday, June 24th. BMO Capital Markets assumed coverage on Teleflex in a report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price target for the company. Needham & Company LLC lifted their price objective on Teleflex from $159.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, August 25th. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a research note on Sunday, August 9th. Finally, Mizuho increased their target price on Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, July 15th.

Get Teleflex alerts:

View Our Latest Stock Analysis on Teleflex

Institutional Investors Weigh In On Teleflex

Hedge funds and other institutional investors have recently made changes to their positions in the company. Hsbc Holdings PLC boosted its holdings in Teleflex by 4.7% in the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock valued at $222,000 after acquiring an additional 84 shares during the last quarter. Banque Cantonale Vaudoise increased its position in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after purchasing an additional 113 shares during the period. Hantz Financial Services Inc. raised its holdings in Teleflex by 40.5% during the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 113 shares during the last quarter. Leonteq Securities AG raised its holdings in Teleflex by 13.6% during the 1st quarter. Leonteq Securities AG now owns 1,164 shares of the medical technology company’s stock worth $139,000 after purchasing an additional 139 shares during the last quarter. Finally, CIBC Asset Management Inc lifted its position in shares of Teleflex by 3.4% in the 4th quarter. CIBC Asset Management Inc now owns 4,380 shares of the medical technology company’s stock worth $535,000 after purchasing an additional 145 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Down 2.0%

Shares of TFX stock opened at $125.39 on Friday. Teleflex has a 12 month low of $100.18 and a 12 month high of $145.00. The firm has a market cap of $5.31 billion, a PE ratio of -5.38, a price-to-earnings-growth ratio of 0.85 and a beta of 0.82. The stock has a 50 day moving average of $135.33 and a 200-day moving average of $128.44. The company has a quick ratio of 2.12, a current ratio of 2.60 and a debt-to-equity ratio of 0.94.

Teleflex (NYSE:TFX – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.28 by $0.48. The firm had revenue of $570.33 million during the quarter, compared to analysts’ expectations of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The company’s revenue for the quarter was up 28.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, equities analysts predict that Teleflex will post 7.26 EPS for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex’s dividend payout ratio is currently -5.84%.

About Teleflex

(Get Free Report)

Teleflex Incorporated is a global medical technology company that develops, manufactures and supplies specialty medical devices for hospitals, clinicians and other health care providers. Its products are designed to support procedures in areas including vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgery and urology.

The company’s portfolio includes Arrow branded vascular access and catheter products, airway management devices, regional anesthesia products, surgical instruments, interventional devices and urological products.

Featured Articles

• Five stocks we like better than Teleflex
• Aeluma’s Selloff Could Be Setting Up Its Next Big Move
• Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
• The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
• The Fed’s Rate Hike Could Backfire If Oil Prices Collapse

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.